-
公开(公告)号：EP0445742B1
公开(公告)日：1997-06-04
申请号：EP91103329.8
申请日：1991-03-05
发明人： Inagi, Toshio , Muramatsu, Toyojiro , Nagai, Hidetaka , Murata, Kazuo, c/o Yuasa Battery Co., Ltd. , Takeuchi, Kenichi, c/o Yuasa Battery Co., Ltd. , Izuchi, Shuichi, c/o Yuasa Battery Co., Ltd.
IPC分类号： A61N1/30
-
公开(公告)号：EP0445742A1
公开(公告)日：1991-09-11
申请号：EP91103329.8
申请日：1991-03-05
发明人： Inagi, Toshio , Muramatsu, Toyojiro , Nagai, Hidetaka , Murata, Kazuo, c/o Yuasa Battery Co., Ltd. , Takeuchi, Kenichi, c/o Yuasa Battery Co., Ltd. , Izuchi, Shuichi, c/o Yuasa Battery Co., Ltd.
IPC分类号： A61N1/30
摘要： An electrotherapeutic device for passing a DC electric current through a living organism by applying a voltage to the living organism is disclosed. A device is provided with a battery with an internal resistance of high impedance of a degree that the changes in the resistance value of the living organism can be disregarded. By doing so, no excessive flow of current is produced even if the resistance of the living organism fluctuates. The device is safe, easy to handle, and inexpensive. It is particularly suited for use with iontophoresis; a technology by which drugs are administered by means of the passage of electricity.
摘要翻译： 公开了一种通过向生物体施加电压使直流电流通过活体的电疗装置。 设备具有电阻器，该电池具有可以忽略生物体的电阻值的变化程度的高阻抗的内阻。 通过这样做，即使生物体的抗性波动也不会产生过大的电流。 该设备安全，易于处理，价格便宜。 特别适用于离子电渗疗法; 药物通过电力进行管理的技术。
-
公开(公告)号：EP0055029A3
公开(公告)日：1982-09-15
申请号：EP81305526
申请日：1981-11-24
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K09/06 , A61K07/48 , A61K31/405
CPC分类号： A61K9/0014 , A61K8/492 , A61K31/405 , A61K47/10 , A61K47/14 , A61K47/18 , A61K47/44 , A61Q19/00 , A61Q19/004
摘要： An external preparation for the treatment of dermatoses is in the form of an ungelled ointment or cream comprising indomethacin as an active component and preferably also containing an adjuvant for increasing the release of indomethacin from the preparation. Such preparations exhibit a superior remedial effect when applied directly to any affected parts of the skin.
-
公开(公告)号：EP0258761B1
公开(公告)日：1991-11-06
申请号：EP87112164.6
申请日：1987-08-21
IPC分类号： A61K33/18
CPC分类号： A61K33/18 , A61K31/70 , A61K2300/00
-
公开(公告)号：EP0093563A2
公开(公告)日：1983-11-09
申请号：EP83302348.4
申请日：1983-04-26
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K9/08 , A61K31/405 , A61K47/00
CPC分类号： A61K9/7076 , A61K9/0014 , A61K31/405 , A61K47/08 , A61K47/10 , Y10S514/97
摘要： A pharmaceutical preparation for endermic application is disclosed which comprises indomethacin and at least one solubilizer selected from C 10 terpenoids and C 10 phenols. The addition of these solubilizers in small quantities significantly increase the solubility and stability of indomethacin in various solvents and thus produce indomethacin solutions which can be used perse, or incorporated in a wide variety of bases to provide endermically-applicable preparations of various forms.
-
公开(公告)号：EP0258761A1
公开(公告)日：1988-03-09
申请号：EP87112164.6
申请日：1987-08-21
IPC分类号： A61K33/18
CPC分类号： A61K33/18 , A61K31/70 , A61K2300/00
摘要： A wound-healing preparation is composed of 50 - 90 wt.% of a sugar, 0.5 - 10 wt.% of povidone-iodine, and 1 - 20 wt.% of water. A buffer is also contained in an amount sufficient to adjust the pH of the preparation to 3.5 - 6. Preferably, the preparation may additionally contain 0.1 - 5 wt.% of an agent for imparting an appropriate consistency and stability, which is selected from polysaccharides and derivatives thereof.
摘要翻译： 伤口愈合制剂由50-90重量％的糖，0.5-10重量％的聚维酮碘和1-20重量％的水组成。 还含有足以将制剂的pH调节至3.5-6的缓冲剂。优选地，制剂可另外含有0.1-5重量％的赋予适当稠度和稳定性的试剂，其选自多糖 及其衍生物。
-
公开(公告)号：EP0055029B1
公开(公告)日：1985-11-21
申请号：EP81305526.6
申请日：1981-11-24
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K9/06 , A61K7/48 , A61K31/405
CPC分类号： A61K9/0014 , A61K8/492 , A61K31/405 , A61K47/10 , A61K47/14 , A61K47/18 , A61K47/44 , A61Q19/00 , A61Q19/004
-
公开(公告)号：EP0093563A3
公开(公告)日：1984-09-12
申请号：EP83302348
申请日：1983-04-26
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K09/08 , A61K31/405 , A61K47/00
CPC分类号： A61K9/7076 , A61K9/0014 , A61K31/405 , A61K47/08 , A61K47/10 , Y10S514/97
摘要： A pharmaceutical preparation for endermic application is disclosed which comprises indomethacin and at least one solubilizer selected from C 10 terpenoids and C 10 phenols. The addition of these solubilizers in small quantities significantly increase the solubility and stability of indomethacin in various solvents and thus produce indomethacin solutions which can be used perse, or incorporated in a wide variety of bases to provide endermically-applicable preparations of various forms.
-
公开(公告)号：EP0093563B1
公开(公告)日：1987-06-16
申请号：EP83302348.4
申请日：1983-04-26
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K9/08 , A61K31/405 , A61K47/00
CPC分类号： A61K9/7076 , A61K9/0014 , A61K31/405 , A61K47/08 , A61K47/10 , Y10S514/97
-
公开(公告)号：EP0055029A2
公开(公告)日：1982-06-30
申请号：EP81305526.6
申请日：1981-11-24
申请人： KOWA COMPANY, LTD.
IPC分类号： A61K9/06 , A61K7/48 , A61K31/405
CPC分类号： A61K9/0014 , A61K8/492 , A61K31/405 , A61K47/10 , A61K47/14 , A61K47/18 , A61K47/44 , A61Q19/00 , A61Q19/004
摘要： An external preparation for the treatment of dermatoses is in the form of an ungelled ointment or cream comprising indomethacin as an active component and preferably also containing an adjuvant for increasing the release of indomethacin from the preparation. Such preparations exhibit a superior remedial effect when applied directly to any affected parts of the skin.
摘要翻译： 用于治疗皮肤病的外用制剂是以不凝胶的软膏或霜剂的形式，其包含消炎痛作为活性成分，并且优选还含有用于增加吲哚美辛从制剂中释放的佐剂。 当直接应用于皮肤的任何受影响部位时，这样的制剂显示出优异的补救效果。
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.011 秒)
